Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed.
Conditions
- Non-small-cell Lung Carcinoma
Interventions
- DIAGNOSTIC_TEST: biopsy
- DIAGNOSTIC_TEST: ctDAN analysis
Sponsor
The Netherlands Cancer Institute
Collaborators